Fact based stock research
Jointown Pharmaceutical (SHSE:600998)


Jointown Pharmaceutical stock research in summary

jzteyao.com


Jointown Pharmaceutical shares have a BUY rating. They are good value and are safely financed, but show below average growth. We recommend buying and holding Jointown Pharmaceutical shares.


Latest Obermatt Ranks


Value Rank 71
Growth Rank 46
Safety Rank 62
Combined Rank 77
Country China
Industry Health Care Distributors
Index SSE Composite
Size class X-Large

January 25, 2019. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()

Google: Jointown Pharmaceutical

News

Videos

Wikipedia about Jointown Pharmaceutical

Management

Employee Satisfaction

Customer Satisfaction

Similar Stocks
All Top 10 Lists
Free Stock Update

Research History: Jointown Pharmaceutical

RESEARCH HISTORY 2016 2017 2018 2019
VALUE
VALUE 52
52
74
71
GROWTH
GROWTH 80
93
46
46
SAFETY
SAFETY 58
58
62
62
COMBINED
COMBINED 80
80
69
77

Last update of Combined Rank: 25-Jan-2019. Stock research history is based on the Obermatt Method. The higher the rank, the better Jointown Pharmaceutical is in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2016 2017 2018 2019
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S) 87
87
86
91
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E) 35
35
54
57
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book) 64
60
68
70
DIVIDEND YIELD
DIVIDEND YIELD 1
1
42
42
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE 52
52
74
71

Last update of Value Rank: 25-Jan-2019. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Jointown Pharmaceutical; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2016 2017 2018 2019
REVENUE GROWTH
REVENUE GROWTH 89
93
42
42
PROFIT GROWTH
PROFIT GROWTH 63
63
80
80
STOCK RETURNS
STOCK RETURNS 51
60
26
26
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH 80
93
46
46

Financial reporting date of Growth Rank: 30-Sep-2018. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Jointown Pharmaceutical.


Safety Metrics in Detail

SAFETY METRICS 2016 2017 2018 2019
LEVERAGE
LEVERAGE 43
30
38
38
REFINANCING
REFINANCING 95
87
96
96
LIQUIDITY
LIQUIDITY 28
13
38
38
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY 58
58
62
62

Financial reporting date of Safety Rank: 30-Sep-2018. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Jointown Pharmaceutical and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Jointown Pharmaceutical from January 25, 2019.